Innocare Pharma Limited Announces Executive Changes
Mr. Jin,
has been an investment director of Hankang Capital since
2017 and was promoted to managing director and partner thereof in 2018 and 2020, respectively.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 HKD | -0.86% | +7.73% | -33.24% |
May. 31 | InnoCare Pharma CEO Boosts Shareholding to 7.16% | MT |
May. 31 | InnoCare Pharma Grants Over 1.7 Million Shares Under Incentive Scheme | MT |
1st Jan change | Capi. | |
---|---|---|
-33.24% | 1.18B | |
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |